The Clorox Company (NYSE:CLX) Stock Position Raised by IHT Wealth Management LLC

IHT Wealth Management LLC lifted its holdings in shares of The Clorox Company (NYSE:CLX) by 20.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,579 shares of the company’s stock after purchasing an additional 789 shares during the quarter. IHT Wealth Management LLC’s holdings in The Clorox were worth $883,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Bank of New York Mellon Corp grew its stake in The Clorox by 4.8% in the 1st quarter. Bank of New York Mellon Corp now owns 1,551,035 shares of the company’s stock valued at $299,164,000 after buying an additional 70,987 shares during the last quarter. Norges Bank acquired a new position in The Clorox in the 4th quarter valued at $254,283,000. Stifel Financial Corp grew its stake in The Clorox by 4.1% in the 1st quarter. Stifel Financial Corp now owns 1,133,754 shares of the company’s stock valued at $218,684,000 after buying an additional 44,189 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in The Clorox by 9.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,123,966 shares of the company’s stock valued at $216,791,000 after buying an additional 96,332 shares during the last quarter. Finally, Champlain Investment Partners LLC acquired a new position in The Clorox in the 1st quarter valued at $200,453,000. Institutional investors own 77.62% of the company’s stock.

CLX opened at $178.84 on Thursday. The Clorox Company has a twelve month low of $170.50 and a twelve month high of $239.87. The business’s 50-day moving average price is $178.55. The company has a debt-to-equity ratio of 2.65, a current ratio of 1.08 and a quick ratio of 0.70. The company has a market capitalization of $22.24 billion, a PE ratio of 24.94, a price-to-earnings-growth ratio of 3.44 and a beta of 0.21.

The Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 29th. The company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.48 by $0.14. The firm had revenue of $1.78 billion during the quarter, compared to analysts’ expectations of $1.86 billion. The Clorox had a net margin of 12.27% and a return on equity of 104.74%. The business’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.89 earnings per share. Sell-side analysts anticipate that The Clorox Company will post 7.58 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 13th. Investors of record on Wednesday, July 28th will be issued a $1.16 dividend. This represents a $4.64 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date of this dividend is Tuesday, July 27th. This is a positive change from The Clorox’s previous quarterly dividend of $1.11. The Clorox’s dividend payout ratio (DPR) is 60.33%.

A number of research firms recently issued reports on CLX. Deutsche Bank Aktiengesellschaft lowered their target price on shares of The Clorox from $195.00 to $186.00 and set a “hold” rating on the stock in a research note on Monday, May 3rd. Barclays restated a “sell” rating and issued a $162.00 price target on shares of The Clorox in a research report on Sunday, April 18th. JPMorgan Chase & Co. decreased their price target on shares of The Clorox from $205.00 to $196.00 and set a “neutral” rating on the stock in a research report on Friday, April 16th. Wells Fargo & Company restated an “underweight” rating on shares of The Clorox in a research report on Monday, May 10th. Finally, Royal Bank of Canada restated a “neutral” rating on shares of The Clorox in a research report on Wednesday, May 5th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $202.33.

The Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

Read More: 52-week highs

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.